Tissue engineered heart repair from preclinical models to first-in-patient studies
Authors Zimmermann WH Journal Current Opinion in Physiology Citation Current Opinion in Physiology 2020, 14:70–77. Abstract The lack of regenerative therapies for the treatment of degenerative diseases, such as heart failure, motivates the search for cell therapeutics. From a technical point of view, cell-based heart repair is approached from two
